Lipopolysaccharides (LPSs) from 17 different Bacteroides fragilis strains were extracted in a two-step procedure. The first step was a hot phenol-water extraction of whole bacteria, resulting in a crude aqueous phase, which after lyophilization in a second step was extracted with a phenol-chloroform-light petroleum mixture. The resulting LPSs, which were essentially free from contaminating nucleic acid, proteins, and capsular polysaccharide, were investigated for their (i) qualitative and quantitative sugar and fatty acid composition, (ii) immunochemical specificity by enzyme-linked immunosorbent inhibition assays, and (iii) particle weight by sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Of the 17 strains, 13 had LPSs which all contained L-rhamnose, D-glucose, D-galactose, and D-glucosamine in approximately the same ratio.
The cell envelope of Bacteroidesfragilis bacteria has been shown to contain two major saccharide containing components, a lipopolysaccharide (LPS) and a capsular polysaccharide (13) . The chemical composition and immunochemical properties of B. fragilis LPS have been subject to investigations, but the results have varied (7, 10, 11) . A main reason for the observed variations has probably been the difficulty in obtaining pure LPS preparations. Most extraction procedures, such as phenol-water extractions or outer membrane extraction, result in preparations which contain both LPS and capsular polysaccharide (13) . A further possibility for variation is the observation that upon several in vitro passages of the B. fragilis strain ATCC 23745, the capsule was replaced by a glycan which was coextracted with the LPS (12) .
We recently showed that B. fragilis LPS can be isolated in pure form by first making a phenol-water extraction of the bacteria, followed by a phenol-chloroform-light petroleum (PCP) extraction of the lyophilized aqueous phase (13) .
Although the results from chemical analyses of the B. fragilis LPS have varied, it is clear that this antigen differs in its composition and biological activity from most aerobic gram-negative bacteria (7) . The polysaccharide part of the LPS appears to lack both a conventional 3-deoxy-D-mannooctulosonic acid and L-glycero-D-mannoheptose (5) . The fatty acid composition of the lipid part of B. fragilis is also different from that of lipid A of enterobacterial LPS since it does not contain 3-hydroxytetradecanoic acid, a major fatty acid in aerobic gram-negative bacteria (25) .
The finding that an antiserum elicited by a purified B. fragilis LPS could identify approximately 90% of clinical isolates of B. fragilis, raised the question of common antigenic determinants (one or more) in the LPS (23) . In the present study, we describe the carbohydrate and fatty acid composition as well as particle weight of LPS purified by PCP extraction from 17 which have previously been analyzed in DNA homology studies (9) . Of these 17 strains, 13 (76%) had a similar monosaccharide composition both qualitatively and quantitatively and were shown to be similar, if not identical, in immunochemical studies with a rabbit antiserum-B. fragilis LPS inhibition system.
MATERIALS AND METHODS
Bacterial strains. The B. fragilis strains used are listed in Table 1 .
Growth conditions. All strains were grown in a 4-liter fermentor (Ultraferm 1601; LKB Produkter, Bromma, Sweden). The composition, preparation of the medium, and the growth conditions were essentially as described earlier (13) . The medium in this study did not contain fetal calf serum.
Extraction of LPS. Pelleted organisms were suspended in water and extracted with phenol-water (24) . After dialysis against tap water for 6 days and against distilled water overnight, the aqueous phase was lyophilized. The 20 ,ug of capsular polysaccharide were applied to the sample wells. The gels were stained by the silver method (22) .
Immunochemical methods. Rabbit antisera against B. fragilis NCTC 9343 and B. fragilis ATCC 23745 LPSs were prepared as described earlier (13) . The enzyme-linked immunosorbent assay (ELISA) was performed as described previously (16) . In ELISA inhibition experiments, serum was preincubated for 1 h with different concentrations of the LPS assayed. The 50% inhibitory value was recorded as the concentration of inhibitor needed to obtain a 50% lowering of the optical density at 400 nm as compared to control tubes with no inhibitor added. RESULTS Isolation of LPSs. All B. fragilis strains were grown in a 4-liter fermentor to late logarithmic phase. The yield of the bacteria was about 2 g/liter (dry weight). The yield of crude aqueous phase after phenol-water extraction corresponded to about 5% of the bacterial mass dry weight (wt/wt). The LPS was subsequently isolated from the lyophilized crude aqueous phase after phenol-water extraction with PCP extraction. The yield of PCP-extractable LPS was about 0.5% of the bacterial mass (wt/wt). All LPS preparations were found to be virtually free of nucleic acids (<5 ,ug/mg of LPS) as assayed by UV spectroscopy. Furthermore, no proteins were present (<5 ,ug/mg of LPS) as determined by the method of Lowry et al. (17) , with bovine serum albumin as standard.
Carbohydrate analyses of LPSs. After hydrolysis of the LPS preparations (0.5 M TFA, 16 h, 100°C), the resulting monosaccharides were reduced with NaBH4, and after acetylation they were analyzed as alditol acetates by gasliquid chromatography ( Table 2) .
The total amounts of carbohydrates in the different B. fragilis LPSs varied between 26 and 66%. In the quantitative and qualitative sugar analysis, five groups could be seen, all containing D-glucosamine, as follows: (i) group (Table 2) . Fatty acids in LPSs. The total amounts of fatty acids in the various LPS preparations varied from 24% (VPI 2552) to 52% (VPI 5631). The 9343 LPS preparation contained the following fatty acids: 13-methyltetradecanoic (15%), 3-hydroxypentadecanoic (16%), 3-hydroxyhexadecanoic (35%), 3-hydroxy-15-methylhexadecanoic (21%), and 3-hydroxyheptadecanoic (6%). The quantitative analysis of the LPSs revealed that the ratios between individual fatty acids were comparable (data not shown). The predominating fatty acids were identified as 3-hydroxyhexadecanoic and 3-hydroxy-15-methylhexadecanoic acids.
SDS-polyacrylamide gel electrophoresis of different B. fragiis LPSs. The LPS preparations from all 17 B. fragilis strains were examined together with capsular polysaccharides from B. fragilis NCTC 9343 and ATCC 23745 by using SDS-polyacrylamide gel electrophoresis. LPSs from Shigella flexneri strains 3a and 4bR were used as internal standards. The LPS isolated from strain 3a is of the smooth type, with an 0 polysaccharide chain that contains several repeating units. The 4bR LPS is of the rough type; it lacks the 0 polysaccharide chain but contains the entire core structure (8) . The S. flexneri 3a LPS was resolved into many bands, each representing a different number of repeating units in the LPS molecule, whereas the 4bR LPS gave one broad band only (Fig. 1) .
All of the 17 B. fragilis LPS preparations were of about the same size as the S. flexneri 4bR LPS. Some of the LPS preparations were not homogeneous. The LPS from B. fragilis strains NCTC 9343, ATCC 23745, E323, Ic650, VPI 2554, VPI 4361, VPI 6815, and TM 4000 showed one major and one minor band. The pure capsular polysaccharides from B. fragilis NCTC 9343 and ATCC 23745 were included as controls (Fig. 1C) . None of the two preparations contained any detectable LPS, and only the NCTC 9343 capsule was visible. As reported earlier (13), these two capsular polysaccharides differ both in chemistry and immunochemical specificity. The difference in the migration in the SDSpolyacrylamide gel electrophoresis can be caused by difference in molecular size or difference in charge or both.
Immunochemical analyses. The immunochemical specificity of the 17 LPS preparations was studied in ELISA inhibition experiments with rabbit antisera elicited against B. fragilis NCTC 9343 and ATCC 23745 LPSs. All investigations were done with the homologous LPS as coating antigen, and the concentration of inhibitors required for 50% inhibition was determined (Fig. 2) . Only results with the B. fragilis NCTC 9343 LPS-antiserum system are shown since studies with the ATCC 23745 LPS-antiserum system gave essentially identical results. LPS from 12 of the strains inhibited in the same range as the NCTC 9343 LPS; 0.05 to 0.3 jig of inhibitor was required for 50% inhibition. All strains belong to groups 1 and 2 in terms of sugar composition ( Table 2 ). The LPSs from VPI 4117 and VPI 2552 were less potent; the concentrations required for 50% inhibition were 5 and 75 p,g, respectively. When the LPS from VPI 4225 and VPI 5631 were used as inhibitors, none reached a 50% inhibition even with 100 ,ug (the highest concentration used). strated by its ability to be extracted by the PCP mixture which preferentially extracts the more hydrophobic LPS found in rough enterobacterial bacteria (3) . We assume that the inability of the PCP mixture to extract the B. fragilis LPSs from intact bacteria probably reflects physicochemical properties of the B. fragilis cell envelope; the LPS may be masked by the capsular polysaccharide.
DISCUSSION
Fatty acid analyses of the 17 different B. fragilis LPS preparations showed that all have a similar lipid composition (data not shown). The main fatty acids are isobranched pentadecanoic acid, 3-hydroxy-pentadecanoic acid, 3-hydroxyhexadecanoic acid, isobranched 3-hydroxyheptadecanoic acid, and 3-hydroxyheptadecanoic acid. The range of 3-hydroxy fatty acids found in the B. fragilis LPS is also quite unique, as found in an earlier study (25) . The 3-hydroxytetradecanoic acid, which is the major fatty acid in enterobacterial LPS, is present in B. fragilis LPS only in trace amounts. Thus, the fatty acid composition as found in this study on 17 different LPSs is in agreement with what our earlier collaborative studies on a few strains have shown (13, 25) . Although different from what has been found for enterobacterial LPSs both in fatty acid composition and in lack of common endotoxic activities (7), the large similarities in fatty acids, both qualitatively and quantitatively suggests that B. fragilis in this respect is a fairly homogenous bacterial species.
The qualitative and quantitative sugar analyses revealed that 16 of 17 strains analyzed contained L-rhamnose, Dgalactose, D-glucose, and D-glucosamine (Table 2 ). For 10 of these strains, the ratios of these sugars were very similar ( Table 2 , group 1). Also, the LPSs from the three strains of group 2 had the same ratio but contained, in addition, D-galactosamine. All these 13 LPSs were in addition to similarities in saccharide composition shown to have the same immunochemical specificity ( Fig. 2; Fig. 2) .
Studies of the polysaccharide chain from the LPS of strain 9343 using methylation analysis have shown that it has the following structure (Weintraub et al., submitted for publication):
This structure has an L-rhamnose/D-galactose/D-glucose ratio of 1:5:1. The data in Table 2 show L-rhamnose/D-galactose/D-glucose ratios of 1:3 to 5:1. The difference in these results may, however, be explained by the fact that the PCP-extracted LPS from the 9343 and other strains was a mixture of two LPS populations (Fig. 1) . We showed that the minor band which can be seen on the SDS-polyacrylamide gel electrophoresis corresponded to an LPS fraction in All LPSs studied contained D-glucosamine ( Table 2 ). The demonstration of amide-linked fatty acids in the B. fragilis LPS (25) indicates that this linkage occurs between the fatty acids and the amino sugar. This would be in accordance with the findings in enterobacterial lipid A in which the backbone is a P-1,6-linked D-glucosamine disaccharide (19) .
The results of the ELISA inhibition experiments are in agreement with our own data showing that approximately 90% of more than 100 clinical isolates of B. fragilis could be identified by using the antiserum elicited by the PCPextracted LPS from the strain NCTC 9343 LPS (23) . Earlier studies had suggested that the capsular polysaccharide was a common antigen for the B. fragilis species (18) . This investigation unequivocally shows that instead the LPS is the common antigen, a hypothesis suggested in an earlier study (13) . Our results also suggest that the various serotyping systems proposed for B. fragilis (2, 6, 15) have been largely based on different antigenic specificities in capsular polysaccharides rather than somatic 0 antigens (i.e., LPSs).
Most of the B. fragilis strains used in this study (except NCTC 10584, TM 4000, andIc650) have earlier been divided into two DNA homology groups (9) , and the relationship between the DNA group and antigenic specificity of the cell envelope was studied (1). It is interesting to note that with one exception (the LPS from strain VPI 5631) we found all strains of DNA homology group I to have LPSs with the same immunochemical specificity. The exceptional strain, VPI 5631, which lacked D-galactose in its LPS, may well be a mutant which has lost the immunochemically active saccharide. Our immunochemical data are not entirely in agreement with those of Babb and Cummins (1). This may be explained by the fact that these investigators used sera elicited by whole bacteria in their serological tests and the antigens were either whole cells or crude cell wall fractions. Consequently antigens and antibodies representative of both the LPS and the capsular polysaccharide of the cell envelope were studied simultaneously.
